Compare PNNT & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PNNT | NRC |
|---|---|---|
| Founded | 2007 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 397.7M | 428.2M |
| IPO Year | 2007 | 1997 |
| Metric | PNNT | NRC |
|---|---|---|
| Price | $4.65 | $16.52 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.85 | N/A |
| AVG Volume (30 Days) | ★ 764.8K | 100.9K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | ★ 20.64% | 3.88% |
| EPS Growth | N/A | ★ 4707.69 |
| EPS | N/A | ★ 50.00 |
| Revenue | N/A | ★ $119,686,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.14 | ★ $0.33 |
| Revenue Growth | N/A | ★ 1.81 |
| 52 Week Low | $4.64 | $9.76 |
| 52 Week High | $7.53 | $22.79 |
| Indicator | PNNT | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 27.96 | 58.97 |
| Support Level | N/A | $14.78 |
| Resistance Level | $6.18 | $16.63 |
| Average True Range (ATR) | 0.14 | 0.89 |
| MACD | -0.01 | 0.60 |
| Stochastic Oscillator | 2.86 | 89.28 |
Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.